Skip to main content
logo
HanchorBio Inc. (TPE:7827)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
156.50
+0.50 (0.32%)
At close: Aug 6, 2026

HanchorBio Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
312.22312.22--3.36
Revenue Growth
-----
Gross Profit
312.22312.22--2.05
Operating Income
-592.16-367.6-952.12-538.05-512.32
Net Income
-512.93-276.72-1,354-591.36-446.32
Earnings Per Share
-4.10-2.26-20.36-11.36-10.09
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
816.011,064405.5415.43246.09
Total Debt
99.51101.3846.261,34755.05
Net Cash (Debt)
716.51963.02359.24-931.28191.04
Net Cash Growth
99.45%168.07%---
Net Cash Per Share
5.737.855.40-17.884.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-437.71-318.42-607.67-439.59-337.62
Capital Expenditures
-18.25-17.16-18.78-22.04-70.78
Free Cash Flow
-455.96-335.58-626.45-461.63-408.39
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%--60.87%
Operating Margin
-189.66%-117.74%---15234.11%
Pretax Margin
-190.78%-118.17%---13270.92%
Profit Margin
-164.28%-88.63%---13271.57%
FCF Margin
-146.04%-107.48%---12143.74%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
65.2636.87---